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Abstract 
 
The hypothesis of the study is that TdP history can be better identified using T-wave 
morphology compared to QTcF at baseline. ECGs were recorded at baseline and during 
sotalol challenge in 20 patients with a history of TdP (+TdP) and 16 patients without 
previous TdP (-TdP). The Fridericia-corrected QT interval (QTcF) and T-wave morphology 
combination score (MCS) were calculated. At baseline, there was no significant difference 
in QTcF between the groups (+TdP: QTcF = 446±9 ms; -TdP: QTcF = 431±9 ms, p = 0.27). 
In contrast, MCS was significantly different between the groups at baseline (+TdP: MCS = 
1.07±0.095; -TdP: MCS = 0.74±0.07, p = 0.012). Both QTcF and MCS could be used to 
discriminate between +TdP and –TdP after sotalol but only MCS reached statistical 
significance at baseline. Combining QTcF with MCS provided a significantly larger 
difference between groups than QTcF alone. 
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Introduction 
 
Drug-induced repolarization abnormalities put vulnerable patients at risk of torsades de 
pointes (TdP) and sudden cardiac death (SCD).
1 
Drugs that inhibit the rapidly activating 
component of the delayed rectifier potassium current in the myocardium (IKr) manifest in the 
ECG by prolonging the QT interval, which has been associated with drug-induced TdP 
and SCD.
2 
A drug-induced QTc prolongation (QT corrected for changes in heart rate) of less 
than 5 ms is unlikely to induce TdP whereas prolongations greater than 20 ms are associated 
with substantially higher risk.
3 
In addition, the risk of TdP increases exponentially at a rate of 
5% with every 10 ms prolongation of QTc beyond 440 ms.
4
 
However, the relation between the prolongation of QTc and proarrhythmic risk is not 
straightforward. QTc is a mediocre parameter for assessing risk of drug-induced TdP and 
there are a number of QTc prolonging drugs with very limited or no proarrhythmic history. 
For instance moxifloxacin,
5-7 
tamoxifen,
8 
and ranolazine
9 
prolong the QTc interval without 
causing arrhythmia. These observations challenge the QTc-based drug safety screening and 
recent studies suggest that repolarization abnormalities can be assessed with a higher degree 
of precision with other electrocardiographic markers.
10-13
 
Several markers based on the properties of the T-wave have been proposed. The interval 
between the peak of the T-wave and the end of the T-wave (TpTe) has received significant 
attention. The T-wave right slope in lead I was found to improve the detection of patients 
with history of TdP if used in combination with QTc.
13
 A prolonged TpTe interval has been 
associated with risk of TdP during acquired bradyarrhythmia when notched T-waves are 
present.
 14  
However, studies of TpTe as a marker of drug-induced repolarization have 
shown conflicting results. For example, an increased TpTe was found in patients treated with 
amiodarone, although amiodarone is antiarrhythmic
15  
TpTe also failed to distinguish the 
symptomatic and asymptomatic patients in congenital long QT syndrome.
16 
Moreover, TpTe 
correlates strongly with QT and thus does not add new information to the QT interval, 
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the latter remaining the preferred marker.
17 
T-wave alternans was also suggested as a 
proarrhythmic risk marker: It was observed just prior to episodes of TdP.
18 
Area based 
markers of the T-wave, such as Relative T-wave Area (RTA), attained their maxima just 
before the onset of TdP in dogs treated with sertindole.
19 
 A  systematic quantification of 
T-wave morphology as defined by Graff et al.
10, 11 
combines three features of T-wave 
morphology: Asymmetry, flatness and notch into a composite score named Morphology 
Combination Score (MCS). MCS was shown to be a robust parameter that may 
improve drug safety studies, for example in cases where the QT interval and some other T-
wave morphology markers show false positive results.
11, 20
 Several markers, including MCS 
parameters, ERD and LRD of the T-wave loop, QRS-T angle, Spatial Ventricular Gradient 
and Total cosine R-to-T were analysed by Vicente et al.
12
 in a study using dofetilide, 
quinidine, ranozil and verapimil. The study showed that the morphological parameters 
effectively identified pure hERG blocking, whereas interval analyses may reveal additional 
sodium and calcium channel blocking that might reduce the torsadogenic risk of a drug.  
Patients with a history of TdP (+TdP) have altered repolarization and, therefore, 
respond more to IKr inhibiting drugs in terms of QTc interval than patients without such 
history (-TdP).
21 
The baseline QTc values in those two groups of patients suggest that 
abnormal repolarization is normally masked and hence stressing the patients with e.g. sotalol 
is required to unmask any an existing repolarization disturbance. In this study, we have 
investigated if the T-wave morphology parameter MCS can be used to identify the +TdP 
patients and –TdP patients at baseline and after sotalol challenge, with QTc as reference 
measure. 
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Results 
 
Study sample 
 
The clinical characteristics of the patients are shown in Table 1. There was no significant 
difference between the average ages of the +TdP and –TdP groups: +TdP 59±12 and -TdP 
62±12 years (p=0.59). The +TdP group consisted of 11 males and 9 females and the -
TdP were 5 males and 11 females. Two-way ANOVA tests, at baseline and at the time of 
maximum response, showed that the results are independent of the different male-female 
ratios in the groups considering both MCS (Baseline: p=0.24; Maximum response: p=0.84) 
and QTcF (Baseline: p=0.59; Maximum response: p=0.79) and the interaction between 
patients’ sex and the presence of the history of drug induced TdP was not statistically 
significant. 
QTcF and MCS 
 
The difference in QTcF at baseline between the +TdP and –TdP groups was not statistically 
significant (Table 2). Five patients had a QTcF duration above a gender specific QTcF 
threshold for LQTS (QTcF >470 ms in men and QTcF >480 ms in women)
22
 which 
comprised four patients (3 male + 1 female) from the +TdP group and one patient (1 female) 
from the –TdP group. Table 2 shows the baseline values and sotalol-induced changes in the 
two groups. 
The QTcF value attained its maximum at twenty-minutes after completion of the drug 
infusion for both groups. The mean difference between the QTcF values for the +TdP and 
–TdP groups at this time was 51.4 ms (p= 0.0018). 
In contrast to QTcF, at baseline the difference (0.33) in MCS between the groups was 
statistically significant (p=0.01). The maximum values of MCS occurred about 20 minutes 
after completion of the drug infusion for both groups. The mean difference in MCS between 
the groups at this time point was 0.38 (p=0.037). 
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Representative ECGs indicating prominent QT interval prolongation and T-wave changes 
during the sotalol infusion (0, 5, 10 15 and 20 minutes) from both the +TdP and –TdP 
groups are shown in Fig. 1. During the drug infusion period of 20 minutes and during about 
20 min. after completion of the infusion, the QT interval increased from baseline for both 
groups. The corresponding changes in the T-wave morphology are associated with increased 
asymmetry, flatness and notching. 
The averages of QTcF and MCS for each five-minute segment during the whole 
experimental period (up to 20 min after infusion) are presented in Fig. 2, with error bars 
indicating the 95% confidence intervals (CI). QTcF increased more in patients with a 
history of TdP as compared with the patients in the –TdP group, (p<0.017). In contrast, the 
change in the T-wave morphology was similar in the two groups (p=0.73). 
Identification of Patients with a History of TdP 
 
A linear discriminant analysis
23 
was used to identify the +TdP and –TdP patients based on 
QTcF and/or MCS values at baseline and at 20 min after completion of the sotalol infusion. 
Table 3 shows the sensitivity (Se), specificity (Sp), positive predictivity (PP) and negative 
predictivity (NP) for the univariate (discriminant analysis based on QTcF and MCS 
separately) and covariate cases (discriminant analysis considering both QTcF and MCS). 
McNemar’s test showed that a combined method, using QTcF and MCS, provides a 
significantly higher accuracy (0.69) of correct identification of patients compared with QTcF-
only (accuracy = 0.50) based identification at baseline (p=0.04).  
This article is protected by copyright. All rights reserved.
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Discussion 
 
Administering IKr inhibiting drugs to the patients with a history of TdP poses substantial risk 
of arrhythmogenesis as evident from their post dose QTcF values. From the analyses of 
Kääb et al.,
21 
and Couderc et al.,
24 
it is evident that the QTcF at baseline was not significantly 
different between the +TdP and -TdP groups which corroborates our QTcF finding. After 
the sotalol infusion, the +TdP group responded with significantly higher QTcF than the –
TdP group. Kääb et al.
21
 reported the higher post-dose QTcF of the +TdP group as 
compared with the –TdP group as the unmasking of the reduced repolarization reserve of 
the former group.
 
The repolarization reserve by definition is a defensive mechanism against 
the triggering of TdP as a result of the interaction of other ion channels.
25 
However, the 
association between drug-induced repolarization changes and the so-called repolarization 
reserve is not clear. We do not have measures to quantify and relate the repolarization reserve 
with ECG parameters. Nevertheless, the higher QTcF of the +TdP group can be assumed to 
reflect their abnormality in repolarization, which agrees with the observations of Sauer et al., 
that higher baseline QTc was associated with discontinuation of sotalol and dofetilide.
26
 
Stress testing has been established as a way to unmask the presence of LQTS.
27 
The 
higher post-dose QTcF of the +TdP group implies the need for a stress test to find patients 
with latent repolarization disturbance. In contrast, MCS already at baseline identifies 
repolarization disturbances with similar accuracy as stress testing with QTcF, thus implying 
that that a combination of QTc and MCS at baseline could eliminate the need for provocative 
stress testing. 
QTcF based correct identification of patients in their respective groups (+TdP or -TdP) 
increased after drug treatment (baseline: 9 post-dose: 14) as shown in Table 3. However, this 
accuracy can be already attained at baseline when both the baseline QTcF and MCS were 
used in the discriminant analysis. On the other hand, there is no significant difference 
This article is protected by copyright. All rights reserved.
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between the number of correct identifications by MCS at baseline (n=12) and by QTcF after 
sotalol treatment (n=14). Hence, again it can be inferred that the combination of the baseline 
values of QTcF and MCS may be used to avoid stress testing. 
Other T-wave based parameter e.g. the T-loop morphology analysis by Couderc
24 
on the 
data of similar groups also shows the differences between groups. A difference in early 
repolarization duration (ERD) between the groups was significant at baseline but not 
significant after sotalol treatment. On the other hand, late repolarization duration (LRD) 
showed the exact opposite response - being similar in the two groups at baseline and 
significantly different after sotalol. This transition of the significance of early and late 
repolarization duration is interesting although the reason for it is unclear. The TpTe between 
the groups was not significantly different at baseline although it attained a significant level 
after the sotalol treatment but with very high standard deviation, which might not be 
clinically useful for identifying individual vulnerable patients.
24
 Also TpTe/QTc was not 
significantly different between the groups, neither at baseline nor after sotalol.
24
 However, 
some other measures related to the risk of TdP may be investigated in future studies. The 
Index of Cardio-Electrophysiological Balance (iCEB=QRS/QT)
28,29
, QT-instability
30
, and the 
Electro-mechanical window (EMW)
31,32
 have shown some potential with respect to QT-
prolongation and the risk of TdP, although EMW would require an echocardiography in 
addition to the ECG. 
We found a larger mean QT interval prolongation after sotalol in the +TdP group 
compared to the -TdP group. This differential QT effect highlights another problem related to 
potential wrongful labelling of the risk associated with a drug. A QT-based risk assessment of 
TdP is obtained from a Thorough QT (TQT) study carried out in healthy volunteers. The 
study is used to assess whether or not a drug will have a QT interval prolonging effect in the 
target population. However, it has never been demonstrated that QT interval data from TQT 
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trials in healthy volunteers can be extrapolated to the target population to identify 
repolarization effects reliably. In fact, our QT results suggest the opposite. Extrapolation to 
the clinical situation based on QT labelling may, therefore, be inappropriate and wrong. On 
the other hand, MCS is a stable parameter and the mean baseline MCS of the –TdP patients 
(0.74) and of the healthy volunteers from another sotalol study by Graff et al. (0.71)
11 
are 
interestingly similar. Furthermore, we emphasize our observation that sotalol had similar 
effects on T-wave morphology in the +TdP and –TdP groups and propose further studies to 
be carried out to investigate if T-wave morphology changes are more consistent across 
different patient populations than QT interval changes. 
The results of this study suggest that T-wave morphology is an indicator of risk of TdP and 
that the standard QT analysis should be enriched with analysis of T-wave morphology in 
patients with suspected pro-arrhythmic tendencies or for screening of patients to be treated 
with QT prolonging drugs such as Class III antiarrhytmics. 
Methods 
 
Study population 
 
The ECG data were obtained from patients with paroxysmal atrial fibrillation (AF) and was 
available from the Medical Center of the University of Munich, Germany. The +TdP group 
(n=20) was defined as patients with a documented history of TdP in association with QT-
prolonging drugs. The –TdP group (n=16) consists of patients who were treated with 
sotalol for their paroxysmal AF and without a history of TdP. All of the patients were 
informed about the study and gave signed consent for the study, which was approved by 
the local ethics committee of the university and the procedures were followed accordingly. 
Study Protocol 
 
The protocol was described by Kääb et al.
21 
In short, all patients rested in supine position for 
60-90 min. prior to testing. Tests were performed between 9:00 and 13:00, and dl-sotalol was 
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infused at a constant rate over a 20-min interval at a dose of 2 mg/kg body weight in both 
groups. All the patients were closely monitored in the ICU from 1 h before to 24 h after 
testing. Digital 12-lead ECGs were recorded as nine consecutive five-minute segments while 
the patients were in a supine position, at baseline (1 ECG segment), during intravenous 
sotalol infusion of 20 minutes (4 ECG segments) and the 20 minutes steady state phase just 
after discontinuing sotalol infusion (4 ECG segments). 
 
ECG Analysis 
 
Median Beat Formation 
 
The central three minutes of each of the five-minute ECG segments were used to derive 18 
median beats in each lead of the 12-lead 10-second recordings in that three minute period. 
The MUSE/Interval Editor software (GE Healthcare, Milwaukee. WI, USA) was used to form 
the median beats. QT-interval and T-wave morphology parameters were calculated from the 
first principal component of each of the 18 median beats. The resulting 18 values were 
subsequently averaged for each five-minute segment. 
QT and T-wave Morphology Measurement 
 
The QT interval was measured using the tangent method described by Lepeschkin et al.
33 
and 
corrected for heart rate with Fridericia’s formula to give QTcF. 
The details of the morphology measurement were presented by Graff et al.
11, 20 
In brief; the 
morphology measure is a combination of the measures of T-wave asymmetry, flatness and 
notching. 
 
Asymmetry was defined as the average squared difference in the slope profiles of the 
ascending and descending part of the T-wave (see Fig. 3A for a normal symmetric T-wave 
and 3B for an asymmetric T-wave). 
This article is protected by copyright. All rights reserved.
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Flatness was calculated as a modified version of the standard kurtosis measure which is used 
to describe the peakedness of a probability distribution (Fig. 3C has a flatter T-wave than 
3A and 3B). 
The notch in the T-wave was quantified by the depth of the nadir near the peak of the T- 
wave. The magnitude of a notch was measured on a unit amplitude T-wave and assigned to 1 
of 3 categories: No notch = 0, moderate notch (perceptible bulge) = 0.5 and pronounced 
notch = 1.0 (distinct protuberance above the apex). Fig. 3D shows a notch in the T-wave. 
 
The morphology measures were linearly combined to yield the Morphology Combination 
Score (MCS) as a measure of the overall description of the T-wave morphology. 
 
MCS Asymmetry1.6FlatnessNotch 
 
ECG measurements were calculated before unblinding of data. 
 
Statistical Analysis 
 
As some of the ECG segments were missing at random, a standard method (Expectation 
Maximization algorithm (EM)
34
) was used to account for the missing values in the statistical 
analysis. All analyses were done in SPSS (IBM SPSS Statistics 21 Inc). A 2-way ANOVA 
was used to account for potential bias due to the different male-female ratios between the 
groups. An independent sample t-test was performed to calculate the significance of the 
differences at baseline and after sotalol infusion between the groups. Linear discriminant 
analysis was used as a measure of distinction between +TdP and -TdP. A McNemar test was 
used for the classification of +TdP and -TdP groups. P<0.05 was considered significant. 
Results are presented as mean±standard error (SE) unless otherwise stated. 
Limitations of the study 
 
The sample size in this study was small (n=36), although it contained ample ECG data of 
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(45 minutes) from each patient. Both groups consisted of patients with paroxysmal AF and 
according to Hong et al., AF has a shortening effect on the QT interval, which indicates that 
the results might be different for different heart diseases.
35
 
The dosage was a single infusion of sotalol, which does not affect the results at baseline, but 
with repeated administration of the drug the results may develop differently over time.  
The automatic calculation of the QT interval is a possible source of error. To mitigate this 
problem we have manually evaluated the resulting QRS-start and T-end points on the ECGs 
without finding errors requiring overreading, although the tangent method as such 
systematically underestimates the QT interval. 
Several interesting parameters have been proposed in the literature. In the current paper we 
have investigated QTc and MCS only. The results encourage future study with other 
promising parameters. 
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Study Highlights 
 
 What is the current knowledge of the topic 
 
Patients with a history of TdP are prone to drug induced repolarization disturbance which 
can trigger TdP. A latent abnormality in repolarization is primarily measured in the ECG as a 
prolongation of the QT interval. However, using the QT interval alone it is difficult to 
identify vulnerable patients without stress testing. 
 
 What question did this study address? 
 
The study investigates if T-wave morphology (MCS) can aid in identifying vulnerable 
patients at risk of TdP. 
 
 What this study adds to our knowledge 
 
At baseline, without the need for stress testing, T-wave morphology but not QTc can be used 
to identify vulnerable patients with a history of TdP (+TdP) and patients without such history 
(-TdP).  
 
 How this might change clinical pharmacology or translational science 
 
T-wave morphology analysis can be used as an adjunct to QTcF measurements to stratify 
patients for TdP risk without drug challenge
This article is protected by copyright. All rights reserved.
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Figure legends 
Figure 1. Representative ECGs (first principal components) during sotalol infusion. Left 
panel: ECG from a patient with a history of TdP (+TdP); Right panel: ECG from a 
patient with no history of TdP (-TdP). 
Figure 2. Development of QTcF and MCS in response to the sotalol infusion. Left panel: 
The development of QTcF from baseline up to 20 min post dose for the +TdP and –TdP 
groups. Right panel: MCS values from baseline up to 20 min post dose. Circles and 
error bars indicate means±95% confidence intervals. 
Figure 3. ECGs with different T-wave morphologies. (A) Normal, (B) Asymmetric, (C) 
Flattened, and (D) Notched T-wave. 
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Table 1: Patient Demographics 
 
 
Age Gender CAD MI HT AF LVEF TdP 
(yrs)      (%) cause 
This article is protected by copyright. All rights reserved.
CAD - Coronary artery disease; MI - myocardial infarction; HT - Hypertension; AF - history of Atrial 
Fibrillation; LVEF - Left Ventricular Ejection Fraction; n.a. - information was not available 
        
+TdP: Group with history of TdP 
70 m yes yes no yes 56 Erythromycin 
 52 m no no yes yes 60 n.a. 
54 f no no no yes 56 Sotalol 
63 m no no no yes 29 Sotalol 
77 f yes yes yes yes 45 Sotalol 
39 m no no no no n.a. Imipramin 
47 f no no yes yes n.a. Diuretic 
72 f no no yes yes n.a. Cipramil 
75 f no no yes yes 60 Sotalol, 
Cipramil, 
Furosemide 
58 m no no no yes 60 Sumatriptane 
61 f no no no no n.a. Bisacodyl 
64 m no no no yes 30 Sotalol 
55 m yes yes yes yes 30 Amiodarone 
72 f no no yes no 30 n.a. 
40 m no no no no 39 Clarithromycin 
65 f no no yes no 63 n.a. 
72 f no no no no 74 n.a. 
45 m no no no yes 36 n.a. 
45 m no no no yes 36 n.a. 
68 m no no yes no 65 n.a. 
        
-TdP: Group without history of TdP 
60 f no no no yes n.a.  
67 f no no yes yes 70  
70 f no no no no 60  
61 f no no yes yes n.a.  
65 f no no no yes n.a.  
70 f n.a n.a. n.a. n.a. n.a.  
64 f no no yes yes n.a.  
62 f no no yes yes 80  
82 f no no yes yes 65  
63 m yes no no yes 50  
56 m no no no yes n.a.  
36 m no no no no 65  
70 f yes no yes yes 64  
54 m yes no yes yes 65  
73 f no no yes no 66  
37 m no no no no 70  
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Table 2: Baseline values and sotalol induced changes (mean ±standard error) 
 
 Baseline Values   Sotalol induced change from baseline 
 -TdP +TdP p  -TdP +TdP p 
Intervals (ms)        
QT 409±7 433±10 0.07 
 
74±13 107±10 0.043
†
 
QTcF 431±9 447±10 0.26 
 
36±10 73±9 0.017
†
 
QTcB 445±12 454±10 0.57 
 
16±14 55±9 0.022
†
 
RR 873±51 924±40 0.42 
 
230±46 207±30 0.67 
 
T-wave Morphology parameters 
MCS 0.74±0.07 1.07±0.09 0.01
†
 
 
0.56±0.12 0.61±0.097 0.73 
Asymmetry 0.096±0.02 0.20±0.04 0.04
†
 
 
0.12±0.04 0.09±0.02 0.67 
Flatness 0.39±0.02 0.47±0.02 0.036
†
 
 
0.16±0.03 0.17±0.01 0.75 
Notch 0.01±0.02 0.11±0.05 0.09 
 
0.18±0.06 0.24±0.07 0.46 
† 
significant        
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Table 3: Sensitivity (Se), Specificity (Sp), Positive Predictivity (PP) and Negative 
Predictivity (NP) at baseline and 20 min post dose 
 
QTcF  MCS  QTcF & MCS 
 Baseline Post dose  Baseline Post dose  Baseline Post dose 
Se 0.45 0.70  0.60 0.65  0.70 0.70 
Sp 0.56 0.75 
 
0.69 0.75 
 
0.69 0.94 
PP 0.56 0.78 
 
0.71 0.76 
 
0.74 0.93 
NP 0.50 0.67 
 
0.58 0.63 
 
0.65 0.71 
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